Quote:
Originally Posted by 6 FOOT 3
Hopefully good news for the MS community as the first phase III human trial of the first oral drug Fampridine did extremely well in helping patients with MS to walk extremely better compared to placebo trials as these are the last phase trials before possible FDA approval.
News Detail : National MS Society |
good news indeed, it seems within the next few years we may have three new treatments available. There are two others that are finishing up the Phase III trials as well.
Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
